iShares Neuroscience and HeaIBRNETF
13F holders, Q4 2024 (December 31)2holders −3
0new positions
3sold out
$25.40avg. 13F price*
At the end of Q4 2024, 2 institutions reported holding iShares Neuroscience and Hea (IBRN) in their 13F filings, down 3 from Q3 2024. 0 opened new positions and 3 sold out. The largest holders were BlackRock, Inc. ($2.6M) and Principal Securities, Inc. ($19K).
- Company
- iShares Neuroscience and Hea
- CUSIP
- 46436E353
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $530K |
All 13F filers, Q3 2024 → Q4 2024: 8,000 shares bought and 21,212 shares sold, net −13,212 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| BlackRock, Inc. | 0.00% | Add +8.4% | 103,000 | $2.6M |
| Principal Securities, Inc. | 0.00% | No change | 732 | $19K |
"% of holder's portfolio" is IBRN's weight in each manager's 13F, not the share of iShares Neuroscience and Hea the manager owns.